港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

生物医药B类股

515.560

-16.828-3.16%

涨家数：6

跌家数：26

平家数：1

市盈率：- -

高：526.804

开：526.804

低：504.120

收：532.388

成交量：3,725.86万

成交额：9.84亿

市值：3,259.75亿

流通市值：2,915.76亿

数据加载中...

总览新闻资讯

亚虹医药(688176.SH)拟推2026年员工持股计划

利好密集！四季度还看创新药？

再鼎医药将首次公布Zocilurtatug Pelitecan（Zoci）用于广泛期小细胞肺癌一线治疗临床试验的全球数据

亿腾嘉和(06998)9月29日斥资169.99万港元回购100万股

9月医药BD交易密集披露：创新药与类似药出海并进，商业化兑现加速

港股通康方生物净流出5.76亿港元

阿斯达克财经

迪哲医药：公司收到阿斯利康6亿美元首付款

普门科技(688389.SH)：“光子治疗仪”取得医疗器械注册证

归创通桥(02190)9月29日斥资113.83万港元回购5.3万股

ETF日报(09.29)丨国常会释放“稳地产“增量政策信号三大BD落地创新药板块回暖

利好一出，直线拉升！资金大笔流入

《大行》花旗：中生制药(01177.HK)与STADA达成生物类似药战略合作带来惊喜

阿斯达克财经

《大行》里昂：康方生物(09926.HK)海外伙伴Summit(SMMT.US)获阿斯利康投资利好依沃西全球发展

阿斯达克财经

ETF异动 | 华夏创新药(03525)涨超2% 聚焦香港及全球发达市场中研发驱动型优质创新药企业

港股异动 | 礼邦医药-B(09637.HK)午后涨近8% AP308/PKU308获美国FDA临床试验许可

港股异动 | 基石药业-B(02616)涨近7% ESMO数据更新在即高管持续增持彰显发展信心

康诺亚-B午后涨逾9% 公司在自免、肿瘤等多个创新药领域具备强竞争优势

港股异动 | 恒瑞医药(01276.HK)午后拉升超5% 创新药海外授权诺和潜在总交易额高达26亿美元

创新药概念股逆市走强康方生物（09926）涨16.85%、康诺亚-B（02162）涨10.32%

礼邦医药－Ｂ(09637)股价上升5.034%，现价港币$24.62

阿斯达克财经

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/BK1574/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":515.5602,"timestamp":1790928487328,"preClose":532.3884,"halted":0,"volume":37258611,"delay":0,"changeRate":-0.031609,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-16.828247,"latestTime":"10-02 16:00:00","open":526.80365,"high":526.80365,"low":504.12042,"amount":983786061.5,"amplitude":0.042607,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791163800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"pbRate":3.967371,"peRate":176.437057,"turnoverRate":0.001378,"increases":5,"decrements":27,"flats":0,"marketCap":325975381968,"floatMarketCap":291576058040},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":526.80365,"amplitude":0.042607,"preClose":532.3884,"low":504.12042,"pbRate":"3.967371","latestPrice":515.5602,"volume":37258611,"delay":0,"open":526.80365,"prevYearClose":556.26263,"prevWeekClose":495.27,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":495.278,"twentyDayClose":515.473,"sixtyDayClose":490.453,"secType":"PLATE","market":"HK","turnoverRate":0.001378,"peRate":176.437057,"marketCap":325975381968,"floatMarketCap":291576058040,"timestamp":1790928487328,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":6,"down":26,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671216110","title":"亚虹医药(688176.SH)拟推2026年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216110","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216110?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 19:12","pubTimestamp":1790680325,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚虹医药 发布2026年员工持股计划(草案)，持股计划经公司股东会审议批准后，将通过非交易过户等法律法规允许的方式取得并持有公司回购专用证券账户所持有的公司股份，合计不超过587.1735万股，约占公司当前股本总额的1.03%。其中拟首次授予476万股，预留111.1735万股。持股计划的存续期为60个月，自公司公告首次授予部分最后一笔标的股票过户至本员工持股计划名下之日起算。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688176","BK1161","BK1515","159938","09939","BK1574","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216571","title":"利好密集！四季度还看创新药？","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216571","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216571?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 19:08","pubTimestamp":1790680080,"startTime":"0","endTime":"0","summary":"政策、产业、药企、AIDD、业绩等多重利好共振，四季度还看创新药？❗ 全链布局创新药，关注T+0交易利器👇🏻💊 港股通创新药ETF华宝#520880🎯 100%布局创新药研发类公司🧬 港股通医疗ETF华宝#159137🎯CXO含量超50%MACD金叉信号形成，这些股涨势不错！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-29/doc-initnwnc6178502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","LNGR","IBBQ","BK1161","MEDX","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195217404","title":"再鼎医药将首次公布Zocilurtatug Pelitecan（Zoci）用于广泛期小细胞肺癌一线治疗临床试验的全球数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1195217404","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195217404?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 19:02","pubTimestamp":1790679762,"startTime":"0","endTime":"0","summary":"再鼎医药将首次公布Zocilurtatug Pelitecan（Zoci）用于广泛期小细胞肺癌一线治疗临床试验的全球数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2488822045.USD","BK1574","BK1588","09688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671951215","title":"亿腾嘉和(06998)9月29日斥资169.99万港元回购100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671951215","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671951215?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 18:49","pubTimestamp":1790678959,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿腾嘉和(06998)发布公告，于2026年9月29日，该公司斥资169.99万港元回购100万股股份，每股回购价1.695-1.7港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","06998","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671152612","title":"9月医药BD交易密集披露：创新药与类似药出海并进，商业化兑现加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2671152612","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671152612?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 18:48","pubTimestamp":1790678880,"startTime":"0","endTime":"0","summary":"即将过去的九月，中国医药行业BD（业务拓展）交易密集官宣。9月29日，恒瑞医药（600276.SH，1276.HK）宣布，与诺和诺德就其研发的潜在每周一次口服GLP-1和GIP双受体激动剂HRS-1596达成合作。诺和诺德将获得该管线在大中华地区以外的全球独家权利。该交易潜在总额最高可达26亿美元，其中包括3亿美元的首付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609293886585127.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609293886585127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LNGR","BK1574","BK1161","MEDX","159992","06978","150131","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671132252","title":"港股通康方生物净流出5.76亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671132252","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671132252?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 18:25","pubTimestamp":1790677500,"startTime":"0","endTime":"0","summary":"北水南向净流入小米集团、智谱及建滔积层板，分别达3.84亿港元、1.62亿港元及7,553万港元。北水南向净流出康方生物、中芯及阿里巴巴，分别达5.76亿港元、5.68亿港元及5.52亿港元。港股通(沪)最高资金净流入活跃股份为友邦8.09亿港元，而最高资金净流出股份为康方生物4.13亿港元。全日南向合计净流出0港元，总成交额为640.15亿元，占大市成交额34.67%。)相关内容《大行》里昂：康方生物海外伙伴Summit获阿斯利康投资  利好依沃西全球发展AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220706133342587_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220706133342587_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1547030/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1547030/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2476274720.SGD","IE00B5MMRT66.SGD","LU0634319403.HKD","LU0348783233.USD","LU0348735423.USD","LU1794554557.SGD","LU0348784397.USD","BK1574","LU0348766576.USD","09926","IE00B543WZ88.USD","LU2778985437.USD","KURE","LU0417516738.SGD","LU1720050803.USD","LU0417516902.SGD","LU0348827113.USD","LU2488822045.USD","LU0348767384.USD","LU2399975544.HKD","LU0417516571.SGD","LU0561508036.HKD","BK1161","LU1961090484.USD","LU0348825331.USD","IE00BPRC5H50.USD","LU0540923850.HKD","LU2476274308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671815218","title":"迪哲医药：公司收到阿斯利康6亿美元首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2671815218","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671815218?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 17:32","pubTimestamp":1790674320,"startTime":"0","endTime":"0","summary":"每经AI快讯，9月29日，迪哲医药公告，公司于2026年7月14日与阿斯利康签署《许可协议》，授予阿斯利康在全球范围内独家开发、商业化舒沃哲的权利，协议于2026年8月31日正式生效。近期公司已 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260929/c680370883.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260929/c680370883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK1161","BK1515","159938","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671903742","title":"普门科技(688389.SH)：“光子治疗仪”取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2671903742","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671903742?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 17:18","pubTimestamp":1790673523,"startTime":"0","endTime":"0","summary":"智通财经APP讯，普门科技(688389.SH)发布公告，公司控股子公司重庆普门创生物技术有限公司于近期收到了重庆市药品监督管理局颁发的《中华人民共和国医疗器械注册证》，该产品为：“光子治疗仪”。上述取得注册证的光子治疗仪，可输出高能窄谱红光和蓝光，支持多种治疗模式，以满足不同用户治疗需求。该产品适用于需要消炎、镇痛，对体表创面止渗液、促进肉芽组织生长、加速愈合的患者，可以在医院科室、诊所、家庭等多种场所使用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688389","BK1574","BK1583","BK0251","GDOC","HART","LGHT","LNGR","MEDX","PTH","RSPH","AGNG","IEIH","159883","09996","BK1100","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671297301","title":"归创通桥(02190)9月29日斥资113.83万港元回购5.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671297301","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671297301?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 16:56","pubTimestamp":1790672174,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，该公司于2026年9月29日斥资113.83万港元回购5.3万股股份，每股回购价格为21.36-21.54港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502068.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","BK1587","02190","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671248292","title":"ETF日报(09.29)丨国常会释放“稳地产“增量政策信号 三大BD落地创新药板块回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2671248292","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671248292?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 16:34","pubTimestamp":1790670871,"startTime":"0","endTime":"0","summary":"行业表现国务院常务会议释放\"稳地产\"增量政策信号，叠加上海楼市新政正式落地，房地产板块逆势上涨，掀起涨停潮，相关ETF涨幅居前。三笔重磅对外授权交易集中落地，叠加国产创新药临床硬数据持续兑现，创新药板块集体回升，相关ETF普涨。截至收盘，创新药ETF银华涨3.07%，报0.704元；恒生创新药ETF华泰柏瑞涨3.01%，报1.402元；港股通创新药ETF汇添富涨2.76%，报1.452元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","FDN","LNGR","IBBQ","BK1161","BK1574","BK4588","MEDX","BK4550","BK4585","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671729288","title":"利好一出，直线拉升！资金大笔流入","url":"https://stock-news.laohu8.com/highlight/detail?id=2671729288","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671729288?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 16:17","pubTimestamp":1790669820,"startTime":"0","endTime":"0","summary":"9月29日，A股市场主要指数集体上涨。上证指数涨0.18%，深证成指涨0.34%，创业板指涨0.09%，科创综指涨0.69%。今日3471只个股上涨，1933只个股下跌。全市场全天成交额为14216亿元，较上一交 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260929/c680363142.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260929/c680363142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU2433249047.HKD","SG9999001176.USD","LU0130517989.USD","LU1989772840.SGD","BK0028","LU2488822045.USD","LU2106854487.HKD","LU2361045086.USD","LU0348827113.USD","LU2461242641.AUD","IE0002141913.USD","LU0417516738.SGD","LU0098860793.USD","LU2097828631.EUR","PAWZ","RXL","LU0477156953.USD","LU0648001328.SGD","LU2324357040.USD","LU0289739699.SGD","SG9999015341.SGD","GDOC","LU1961090484.USD","LU0868494708.USD","IE00BPRC5H50.USD","LU0289739343.SGD","LU0634319403.HKD","LU1974910355.USD","LU0006306889.USD","LU0203345920.USD","MRK","IE00BN8TJ469.HKD","LU1699723380.USD","LU1720050803.USD","SG9999015358.SGD","LU0211331839.USD","LU0405327148.USD","LU1037948541.HKD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0511384066.AUD","BK4534","LU0238689110.USD","IE00BBT3K403.USD","LU1585245621.USD","LU1291159041.SGD","IE00BLSP4452.SGD","BMED","IE00BFTCPJ56.SGD","IXJ","LU1066051811.HKD","LU1989771016.USD","LU1781817850.SGD","LU2360032135.SGD","IE00B1BXHZ80.USD","LU0057025933.USD","LU1983299246.USD","BK0239","LU0965509283.SGD","SG9999013999.USD","LU0124676726.USD","LU0234572021.USD","LU1969619763.USD","LU2125154778.USD","01276","IE00BJT1NW94.SGD","LU2491049909.HKD","BK0187","000002","LU2476274720.SGD","BK0157","SG9999001176.SGD","BK4533","LU0265550359.USD","LU1941712348.USD","BK0180","LU0472753341.HKD","LU1328615791.USD","LU0985320562.USD","LU0561508036.HKD","LU1997245094.SGD","LU2468319806.SGD","LU0265550946.USD","LU2476274308.USD","LU2778985437.USD","LU0203347892.USD","BK0188","IE00BSNM7G36.USD","LU0405327494.USD","XLV","LU2580892862.HKD","LU2495084118.USD","09926","LU0348784397.USD","LU0965509010.AUD","LU1255011170.USD","LU0072461881.USD","LU1037948897.HKD","LU0417516571.SGD","LU2328871848.SGD","LU1093756168.USD","IE00B5MMRT66.SGD","BK4007","LU0070302665.USD","LU0348783233.USD","LU0540923850.HKD","LU1116320901.HKD","LU1066051225.USD","LU0348766576.USD","LU1934455277.USD","LU1917777945.USD","LU0861579265.USD","IE00B4R5TH58.HKD","LU1066053197.SGD","LU1057294990.SGD","IE000M9KFDE8.USD","LU1923622614.USD","SG9999014542.SGD","LU0348735423.USD","LU2289578879.USD","LU2357627491.SGD","BK0196","BK0273","LU0162691827.USD","LU0859254822.USD","FTXH","LU2399975544.HKD","LU0823416689.USD","LU1066051498.USD","LU1093756325.SGD","LU1146622755.USD","LU0965509101.SGD","LU2097828557.USD","IE00BLSP4239.USD","IYH","LU0689626769.HKD","LU2491050154.USD","FHLC","LU2148510915.USD","BK0086","PPH","BK4585","LU1941712264.USD","BK0060","LU2112291526.USD","LU2097828805.USD","IE00B2B36J28.USD","LU0106261372.USD","LU0417516902.SGD","LU0069063385.USD","600276","LU0965508806.USD","BK4550","LU1655091616.SGD","LU2125154935.USD","KURE","LU1116320737.USD","LU1430594728.SGD","LU1580142542.USD","LU2580892789.USD","SG9999014575.USD","LU2097828474.EUR","02202","LU0266013472.USD","IE00B543WZ88.USD","LU1069347547.HKD","LU2491050071.SGD","VHT","SG9999001440.SGD","LU1032466523.USD","SG9999002224.SGD","SG9999014559.SGD","LU2125909247.SGD","LU2361044949.HKD","LU0348767384.USD","LU0942090050.USD","BK4516","SG9999014567.USD","LU2125909593.SGD","BK0178","JDOC","BK4559","TRUH","LU0058720904.USD","LU1064131003.USD","LU1934455194.USD","IHE","LU1989772923.USD","LU0289961442.SGD","LU1162221912.USD","SG9999002232.USD","BK4588","LU0320765646.SGD","LU2023250843.SGD","BK0174","BK1161","IE0009355771.USD","SGXZ57979304.SGD","LU1023059063.AUD","LU2089984988.USD","LU1064130708.USD","LU1201861249.SGD","LU2097828714.EUR","LU1035773651.USD","LU0432979614.USD","LU1571399168.USD","LU0122379950.USD","LU0980610538.SGD","LU1794554557.SGD","LU1997245177.USD","LU1820825898.SGD","BK1574","LU1997244956.HKD","LU0320765489.SGD","LU0348825331.USD","LU2361044865.SGD","LU1929549753.HKD","LU1934455863.HKD","LU2023250504.SGD","LU0208291251.USD","HRTS","BK0183","LU0130102774.USD","LU1061106388.HKD","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671292381","title":"《大行》花旗：中生制药(01177.HK)与STADA达成生物类似药战略合作带来惊喜","url":"https://stock-news.laohu8.com/highlight/detail?id=2671292381","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671292381?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 16:11","pubTimestamp":1790669460,"startTime":"0","endTime":"0","summary":"花旗发表研究报告指，中生制药旗下正大天晴与德国药企STADA就生物类似药达成战略合作，授予STADA在欧盟、瑞士、英国及独立国家联合体商业化帕博利珠单抗生物类似药的独家许可，并可选择拓展至美国及海湾合作委员会成员国市场。花旗认为合作带来惊喜。中生制药透露年内对外授权交易合计首付款及近期里程碑付款达3.55亿美元，潜在总交易金额达34亿美元。花旗维持中生制药“买入”评级，目标价10.8元。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220712104954076_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220712104954076_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1546966/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1546966/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE00BZ08YS42.EUR","BK1521","BK1191","BK1574","01177","HK0000165453.HKD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","01477","BK1515","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671291058","title":"《大行》里昂：康方生物(09926.HK)海外伙伴Summit(SMMT.US)获阿斯利康投资  利好依沃西全球发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2671291058","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671291058?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 15:46","pubTimestamp":1790667960,"startTime":"0","endTime":"0","summary":"里昂发表研究报告指，康方生物海外合作伙伴Summit Therapeutics获阿斯利康投资，有利依沃西全球发展。该行指出，阿斯利康周一宣布向Summit Therapeutics优先股投资20亿美元，并探索依沃西与阿斯利康多款抗体偶联药物的联合用药方案。该行认为，是次交易有利依沃西未来在胃癌方面的全球发展，亦强化Summit现金状况，以进一步推进依沃西的全球开发。(港股报价延迟最少十五分钟。沽空资料截至 2026-09-29 12:25。) (美股为即时串流报价； OTC市场股票除外，资料延迟最少15分钟。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200424093929484_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200424093929484_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1546958/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1546958/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE00B543WZ88.USD","IE00B5MMRT66.SGD","BK1161","LU0348825331.USD","LU2399975544.HKD","LU0348783233.USD","LU2476274720.SGD","LU1720050803.USD","09926","LU0561508036.HKD","LU0634319403.HKD","LU0417516902.SGD","LU0348766576.USD","LU2778985437.USD","LU0348827113.USD","IE00BPRC5H50.USD","LU2488822045.USD","KURE","LU0348784397.USD","LU0348767384.USD","LU1961090484.USD","LU0417516738.SGD","LU2476274308.USD","LU0540923850.HKD","LU0417516571.SGD","BK1574","LU0348735423.USD","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671280299","title":"ETF异动 | 华夏创新药(03525)涨超2% 聚焦香港及全球发达市场中研发驱动型优质创新药企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2671280299","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671280299?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 15:19","pubTimestamp":1790666349,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华夏创新药涨超2%，截至发稿，涨2%，报10.2港元，成交额49.13万港元。据悉，华夏创新药于9月29日正式在港交所上市，该基金由华夏基金（香港）与富兰克林邓普顿合作开发，全称为华夏富兰克林富时创新药ETF，其追踪富时ETF通创新药指数，指数包含30只符合港股通资格的中国香港上市证券及70只发达市场证券，中国香港市场与其他发达市场目标权重分别为65%、35%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["FDN","MEDX","BK1574","LNGR","BK4585","159992","BK4550","06978","BK4588","03525","WSGE","IBBQ","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671296172","title":"港股异动 | 礼邦医药-B(09637.HK)午后涨近8% AP308/PKU308获美国FDA临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2671296172","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671296172?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 14:40","pubTimestamp":1790664029,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","09637","09939","BK1191","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671956822","title":"港股异动 | 基石药业-B(02616)涨近7% ESMO数据更新在即 高管持续增持彰显发展信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2671956822","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671956822?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 14:02","pubTimestamp":1790661761,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，基石药业-B涨近7%，截至发稿，涨6.81%，报5.49港元，成交额3518.91万港元。此外，公司首席执行官、研发总裁及执行董事杨建新于9月17日至22日以个人资金在公开市场上合共购买49.6万股公司股份，总代价逾270万港元。据悉，自2022年8月担任首席执行官以来，杨建新博士已于公开市场累计购买超1421万股公司股份。此次股份购买充分彰显杨博士对公司的长期承诺以及对公司未来业务前景的坚定信心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02616","BK1574","BK4585","BK4588","BK1161","VXUS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671451293","title":"康诺亚-B午后涨逾9% 公司在自免、肿瘤等多个创新药领域具备强竞争优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2671451293","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671451293?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 13:44","pubTimestamp":1790660640,"startTime":"0","endTime":"0","summary":"模拟交易客户端康诺亚-B午后涨超8%，截至发稿，股价上涨8.95%，现报79.70港元，成交额2.37亿港元。本月初，康诺亚宣布已与跨国医药公司 Aeira 就司普奇拜单抗注射液在东南亚和中亚等 18 个国家和地区的上市注册和商业化达成许可协议。中邮证券指出，康诺亚作为国内创新药出海新锐，在自免、肿瘤等多个创新药领域具备强竞争优势。2023年2月，阿斯利康以6300万美元首付款、超过11亿美元的里程碑付款拿下它的全球权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-29/doc-initnmwi2954177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","06978","BK1161","159992","BK1574","BK1587","MEDX","BK1583","02162","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671936782","title":"港股异动 | 恒瑞医药(01276.HK)午后拉升超5% 创新药海外授权诺和 潜在总交易额高达26亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671936782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671936782?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 13:36","pubTimestamp":1790660165,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2543165471.USD","LU0359201885.HKD","01276","BK1191","LU0359201612.USD","LU1023057109.AUD","06978","LU0359202008.SGD","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671293354","title":"创新药概念股逆市走强 康方生物（09926）涨16.85%、康诺亚-B（02162）涨10.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671293354","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671293354?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 13:20","pubTimestamp":1790659249,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念股逆市走强，康方生物 涨16.85%，康诺亚-B涨10.32%，乐普生物涨7.88%，荣昌生物涨5.41%，科伦博泰生物涨5.32%，博安生物涨4.74%，恒瑞医药涨4.02%，再鼎医药涨4.02%。根据Insight数据，除已经在美国获批上市的药物外，已达成出海合作的国产创新药中有27款处于临床后期。其中，依沃西单抗、匹米替尼已在美国申请上市，芦康沙妥珠单抗、伦康依隆妥单抗、SSGJ-707等重点品种处于临床III期。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992749","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","LU2476274308.USD","LU0348783233.USD","02162","LU0196878994.USD","LU1969619763.USD","BK1574","LU1961090484.USD","LU2328871848.SGD","LU2778985437.USD","LU0417516902.SGD","LU0417516571.SGD","LU0348766576.USD","06990","06955","LU0348767384.USD","BK1587","LU1794554557.SGD","09688","09995","BK1161","MEDX","IBBQ","02157","BK1191","01276","LU2543165471.USD","LU1720050803.USD","159992","LU0348825331.USD","09926","KURE","IE00B5MMRT66.SGD","LU2476274720.SGD","LU1023057109.AUD","LU0348827113.USD","LU0561508036.HKD","LU0634319403.HKD","LU0359201612.USD","LU0348735423.USD","BK1588","IE00BPRC5H50.USD","LU0348784397.USD","LU0359201885.HKD","LU2488822045.USD","BK1583","LU0359202008.SGD","IE00B543WZ88.USD","06978","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671680260","title":"礼邦医药－Ｂ(09637)股价上升5.034%，现价港币$24.62","url":"https://stock-news.laohu8.com/highlight/detail?id=2671680260","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671680260?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 11:45","pubTimestamp":1790653500,"startTime":"0","endTime":"0","summary":"[上升股]礼邦医药－Ｂ(09637) 股价在上午11:45比前收市价上升5.034%，现股价为港币$24.62。至目前为止，今日最高价为$24.62，而最低价为$23.54。总成交量为25.52万股，总成交金额为港币$611.442万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609291329/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609291329/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1161","159938","BK1574","09939","09637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":4,"totalSize":322,"code":"91000000","status":"200"}]}}